6 results
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Species: • Mycobacterium ... inhibitors • Injection drug ... Tuberculosis Treatment ... Initiating Treatment ... Diagnosis #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Species: • Mycobacterium ... inhibitors • Injection drug ... Tuberculosis Treatment ... Initiating Treatment ... Diagnosis #Management #Treatment
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
RIPE Therapy - Drug ... Microbiologically Confirmed Pulmonary ... #Tuberculosis #ActiveTB ... Therapy #regimens #medications ... IDSA #Guidelines #Treatment
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
Treating Disseminated Mycobacterium ... Prophylaxis): Indications ... which may include mycobacterial ... Note: Active TB ... IDSA #Prevention #Treatment
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Recommendations for Treating Mycobacterium ... prevent TB disease) Indications ... no evidence of active ... for active or latent ... #LTBI #Mycobacterium
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
Lymphadenitis, pulmonary ... lymphadenitis, pulmonary ... , hypoxia, and pulmonary ... organizing PNA • Mycobacterium ... • Persistently active